Reply: Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23(6):641-649.

J Med Econ

LEO Pharma, Ballerup, Denmark, and Madison, NJ, USA.

Published: December 2020

Download full-text PDF	Source
http://dx.doi.org/10.1080/13696998.2020.1835857	DOI Listing

Publication Analysis

reply hansen

hansen patel

patel effectiveness

effectiveness comparison

comparison incremental

incremental cost-per-responder

cost-per-responder analysis

analysis calcipotriene

calcipotriene 0005%/betamethasone

0005%/betamethasone dipropionate

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!